{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:08Z","timestamp":1740107708852,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10067-023-06771-w","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:02:15Z","timestamp":1694822535000},"page":"3407-3410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Golimumab-induced posterior reversible encephalopathy syndrome (PRES): a case-based review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-011X","authenticated-orcid":false,"given":"Ezgi","family":"\u00c7imen G\u00fcne\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5703-6739","authenticated-orcid":false,"given":"Seda","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-1503","authenticated-orcid":false,"given":"Emre","family":"Tekg\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-3539","authenticated-orcid":false,"given":"Muhammet","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-3417","authenticated-orcid":false,"given":"Sedat","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"6771_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494\u2013500. https:\/\/doi.org\/10.1056\/NEJM199602223340803","journal-title":"N Engl J Med"},{"key":"6771_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s10067-015-3055-2","volume":"34","author":"A Budhoo","year":"2015","unstructured":"Budhoo A, Mody GM (2015) The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus. Clin Rheumatol 34:2127\u20132134. https:\/\/doi.org\/10.1007\/s10067-015-3055-2","journal-title":"Clin Rheumatol"},{"key":"6771_CR3","first-page":"464","volume":"7","author":"M Tek\u015fam","year":"2001","unstructured":"Tek\u015fam M, Casey SO, Michel E, Truwit CL (2001) Posterior reversibl ensefalopati sendromu: patofizyoloji ve ileri MRG teknikleri ile korelasyon. Diagn Interv Radiol 7:464\u2013472","journal-title":"Diagn Interv Radiol"},{"key":"6771_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jbspin.2015.08.002","volume":"83","author":"T Mah\u00e9vas","year":"2016","unstructured":"Mah\u00e9vas T, Lidove O, Yahia SA, Hayet S, Xerri-Campano B, Ziza JM (2016) Posterior reversible encephalopathy syndrome (PRES) in a patient taking adalimumab for spondyloarthritis. Joint Bone Spine 83:243\u2013244. https:\/\/doi.org\/10.1016\/j.jbspin.2015.08.002","journal-title":"Joint Bone Spine"},{"key":"6771_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00415-008-0732-y","volume":"255","author":"O Kastrup","year":"2008","unstructured":"Kastrup O, Diener HC (2008) TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome. J Neurol 255:452\u2013453. https:\/\/doi.org\/10.1007\/s00415-008-0732-y","journal-title":"J Neurol"},{"key":"6771_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.crohns.2011.06.011","volume":"5","author":"R Haddock","year":"2011","unstructured":"Haddock R, Garrick V, Horrocks I, Russell RK (2011) A case of posterior reversible encephalopathy syndrome in a child with Crohn\u2019s disease treated with Infliximab. J Crohns Colitis 5:623\u2013627. https:\/\/doi.org\/10.1016\/j.crohns.2011.06.011","journal-title":"J Crohns Colitis"},{"key":"6771_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/MPG.0b013e31818aedb4","volume":"48","author":"V Zamvar","year":"2009","unstructured":"Zamvar V, Sugarman ID, Tawfik RF, Macmullen-Price J, Puntis JW (2009) Posterior reversible encephalopathy syndrome following infliximab infusion. J Pediatr Gastroenterol Nutr 48:102\u2013105. https:\/\/doi.org\/10.1097\/MPG.0b013e31818aedb4","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6771_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/MCG.0000000000000557","volume":"50","author":"S Chow","year":"2016","unstructured":"Chow S, Patnana S, Gupta NK (2016) Posterior reversible encephalopathy syndrome in a patient with Crohn\u2019s disease on infliximab. J Clin Gastroenterol 50:687. https:\/\/doi.org\/10.1097\/MCG.0000000000000557","journal-title":"J Clin Gastroenterol"},{"key":"6771_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MPG.0b013e3181a9f95d","volume":"50","author":"V Zamvar","year":"2010","unstructured":"Zamvar V, Puntis JW (2010) Re: \u201cPosterior reversible encephalopathy syndrome following infliximab infusion.\u201d J Pediatr Gastroenterol Nutr 50:353. https:\/\/doi.org\/10.1097\/MPG.0b013e3181a9f95d","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6771_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clml.2016.12.004","volume":"17","author":"AE Floeter","year":"2017","unstructured":"Floeter AE, Patel A, Tran M, Chamberlain MC, Hendrie PC, Gopal AK, Cassaday RD (2017) Posterior reversible encephalopathy syndrome associated with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin) chemotherapy. Clin Lymphoma Myeloma Leuk 17:225\u2013230. https:\/\/doi.org\/10.1016\/j.clml.2016.12.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6771_CR11","first-page":"1038","volume":"23","author":"DJ Covarrubias","year":"2002","unstructured":"Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23:1038\u20131048","journal-title":"AJNR Am J Neuroradiol"},{"key":"6771_CR12","doi-asserted-by":"publisher","unstructured":"Legriel S, Pico F, Azoulay E (2011) Understanding posterior reversible encephalopathy syndrome. In: Vincent JL (ed) Annual update in intensive care and emergency medicine 2011. Springer, Berlin, Heidelberg, pp 631\u2013653. https:\/\/doi.org\/10.1007\/978-3-642-18081-1_56","DOI":"10.1007\/978-3-642-18081-1_56"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06771-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06771-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06771-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:17:37Z","timestamp":1699687057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06771-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6771"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06771-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2023,9,16]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Information concerning the manuscript was provided to the patient. Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}